Publications by authors named "Per Nived"

Claim this Profile
T
The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).
Martina Frodlund, Per Nived, Katerina Chatzidionysiou, Anna Södergren, Eva Klingberg

Microbiol Spectr· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA).
Martina Frodlund, Per Nived, Aikaterini Chatzidionysiou, Anna Södergren, Eva Klingberg

Vaccine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate Treatment Suppresses Monocytes in Nonresponders to Pneumococcal Conjugate Vaccine in Rheumatoid Arthritis Patients.
Evelina Elmér, Per Nived, Åsa Pettersson, Lillemor Skattum, Thomas Hellmark

J Immunol Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients.
Per Nived, Åsa Pettersson, Göran Jönsson, Anders A Bengtsson, Bo Settergren

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson

Arthritis Res Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
Per Nived, Göran Jönsson, Bo Settergren, Jon Einarsson, Tor Olofsson

Arthritis Res Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren's syndrome without disease modifying treatment.
Per Nived, Tore Saxne, Pierre Geborek, Thomas Mandl, Lillemor Skattum

BMC Rheumatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to pneumococcal conjugate vaccine in patients with systemic vasculitis receiving standard of care therapy.
Per Nived, Johanna Nagel, Tore Saxne, Pierre Geborek, Göran Jönsson

Vaccine· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.
Per Nived, Charlotte Sværke Jørgensen, Bo Settergren

Vaccine· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Unexpectedly few findings of tuberculosis in foreign-born pregnant women. Results of screening in northeastern Skåne].
Rolf Alsterlund, Per Nived

Lakartidningen· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis